SCHEDULE: Brera Holdings PLC: Stakeholder Group Files Schedule 13D

A group of entities and individuals, including BREA Holdings LLC and Boustead & Company Ltd., have filed a Schedule 13D, disclosing beneficial ownership of Brera Holdings PLC Class B Ordinary Shares and expressing concerns over management and board actions.

Summary

• A group of reporting persons, including BREA Holdings LLC, Boustead & Company Ltd., Pinehurst Partners LLC, Boustead Securities, LLC, Daniel J. McClory, Keith C. Moore, Alberto Libanori, and Lincoln J. Smith, have collectively filed a Schedule 13D regarding their beneficial ownership of Brera Holdings PLC Class B Ordinary Shares.
• The filing details the number of shares beneficially owned by each reporting person, with total beneficial ownership for the group amounting to a significant stake.
• The reporting persons express concerns regarding the current board of directors and management team, citing a decline in shareholder value and specific actions they believe have not served shareholder interests.
• These actions include a Strategic Advisory Agreement, an Advisory Services Agreement with Pulsar Group Ltd., the adoption of a Rights Agreement (poison pill), and a registered direct offering to certain individuals.
• The group intends to review their investment and may engage in further communications or actions concerning the company's strategy, governance, and performance.

Sentiment

Score: 2

Explanation: StockSavvy.ai views this filing as having a strongly negative sentiment due to the explicit criticism of management, accusations of shareholder value destruction, and concerns about corporate governance practices.

Positives

• The reporting persons have acquired a substantial beneficial ownership stake in Brera Holdings PLC, indicating a belief in the company's potential value.
• The filing provides transparency regarding the ownership and intentions of a significant group of shareholders.

Negatives

• The reporting persons express strong dissatisfaction with the current board and management, citing "substantial destruction of shareholder value" and "highly concerning conduct."
• Specific actions by the board and management, such as advisory agreements and a 'poison pill' rights agreement, are viewed as entrenching leadership and diluting shareholder power.
• A recent registered direct offering to two individuals is highlighted as a related party transaction that appears to have bypassed standard financial analysis and potentially received a waiver under the poison pill.
• The group disputes the company's assertion of a "clear mandate" from the recent annual general meeting, pointing to a narrow margin in director elections following share issuances to management.

Risks

• The reporting persons believe "meaningful change in the Issuer's leadership is urgently needed" due to perceived mismanagement and destruction of shareholder value.
• Concerns are raised about the impact of a "poison pill" rights agreement on shareholders' ability to effect change or act collectively.
• Allegations of breaches of duties by directors are noted, referencing a complaint filed by RBCH Ltd.
• The potential for further dilution of shareholder value through future offerings or transactions is implied by the group's concerns about current management practices.

Future Outlook

The reporting persons intend to continuously review their investment in Brera Holdings PLC. Depending on various factors, they may engage in further communications with management and the Board, discuss potential business combinations or dispositions, make proposals regarding changes to capitalization, ownership structure, or Board composition, or purchase/sell shares, engage in hedging transactions, or change their intentions regarding any of these matters.

Management Comments

• The Reporting Persons believe that the Issuer's current board of directors and management team have presided over substantial destruction of shareholder value and engaged in highly concerning conduct, and that meaningful change in the Issuer's leadership is urgently needed.
• The Board and management have overseen a precipitous decline in the price of the Shares, requiring a 10-for-1 reverse share split to enable the Issuer to maintain a minimum bid price of at least $1 per Share for continued listing on Nasdaq.
• The Reporting Persons expect these actions significantly impacted the results of the Issuer's annual general meeting of its shareholders held in late June - the gap between the votes 'for' and 'against' the election of four out of five incumbent directors (including Mr. Sade and Ms. Maimon) was approximately 1.8 million shares, which is notably less than the number of shares issued to Mr. Sade and Ms. Maimon shortly before the record date for the annual meeting.
• It appears this related party transaction received a waiver under the recently adopted poison pill in order for Mr. Sade and Ms. Maimon to be able to acquire the Shares and increase their ownership above the 9.99% trigger threshold.

Industry Context

StockSavvy.ai notes that this Schedule 13D filing by a group of investors, including investment banking and securities firms, signals potential activist intent within the financial services or technology sectors where Brera Holdings PLC operates. Such filings often precede efforts to influence corporate strategy, governance, or management, especially when significant shareholder value concerns are articulated.

Comparison to Industry Standards

• The filing does not provide direct financial results or operational metrics that can be compared to industry standards.
• The concerns raised about management actions, such as advisory agreements and a 'poison pill', are common tactics observed in situations where activist investors believe a company is underperforming or its governance is not aligned with shareholder interests.
• The specific details of the Strategic Advisory Agreement and the Advisory Services Agreement with Pulsar Group Ltd. would require comparison to similar agreements in the industry to assess their reasonableness, but the filing suggests they are excessive.
• The registered direct offering to two individuals without a fairness opinion is a point of concern, as industry best practices often involve independent financial analysis for significant related-party transactions.

Corporate Governance

Legal Proceedings

• A complaint was filed in the Supreme Court of the State of New York by RBCH Ltd. on June 22, 2026, alleging breaches of duties by certain directors of the Issuer, among other claims.

Related Party Transactions

• On September 18, 2025, the Issuer entered into a Strategic Advisory Agreement with four members of the Board, including the CEO, for significant compensation including pre-funded warrants and common warrants.
• On February 9, 2026, the Issuer entered into an Advisory Services Agreement with Pulsar Group Ltd., an entity where three Board members serve as directors and the CEO serves as a partner, for a total fee of $6 million.
• On May 21, 2026, the Issuer undertook a registered direct offering of 2,298,000 Shares to only two individuals, Mr. Sade and director Keren Maimon, without a fairness opinion or independent financial analysis, which appears to have received a waiver under the 'poison pill'.

Stakeholder Impact

• Shareholders: Potential dilution of voting power and value due to management actions and offerings; concerns about entrenchment of current leadership.
• Management and Board: Facing scrutiny and potential pressure for change from the reporting persons due to perceived underperformance and concerning conduct.
• Creditors: Indirect impact through potential changes in company strategy or financial performance driven by activist investor involvement.

Next Steps

• The reporting persons may endeavor to increase or decrease their position in the Issuer through purchases or sales of Shares.
• They may engage in additional communications with management and the Board.
• They may engage in discussions with the Issuer, shareholders, or other third parties about the Issuer and their investment.
• They may make recommendations or proposals to the Issuer concerning changes to capitalization, ownership structure, Board structure, or operational performance.
• They may engage in short selling or hedging transactions with respect to the Shares.

Key Dates

Recommendation

The filing indicates significant concerns from a group of investors regarding management and governance, suggesting potential for activist intervention. However, without specific financial performance data or a clear plan for immediate change, a 'hold' recommendation is prudent to observe further developments and the group's strategic actions.

Keywords

Brera Holdings PLC, Schedule 13D, Beneficial Ownership, Boustead Securities, Boustead & Company, Corporate Governance, Shareholder Value, Management Concerns